<DOC>
	<DOC>NCT02327689</DOC>
	<brief_summary>This study evaluates generic emtricitabine(FTC) plus adefovir dipivoxil in Chinese naive HBV related cirrhosis patients. Patients were divided into 2 groups: compensated HBV related cirrhosis patients and decompensated HBV related cirrhosis patients.</brief_summary>
	<brief_title>Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients</brief_title>
	<detailed_description>Generic emtricitabine(FTC) has been approved for treatment of naive chronic hepatitis B(CHB) patients in China. Yet data are limited for this agent plus adefovir dipivoxil in cirrhosis patients. The investigators design this trial to test the effect of FTC plus adefovir dipivoxil in Chinese naive compensated and decompensated HBV related cirrhosis patients.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Dignosed cirrhosis patients HBsAg positive for more than 6 months HBV DNA detectable Nucleoside/nucleotide naive patients Diagnosed HCC with AFP and ultrasound, CT or MRI Creatine ＞130μmol/L or Ccr &lt; 70mL/min Hemoglobin &lt;100g/L Coinfected with HAV,HEV,HCV,HDV or HIV ANA ＞ 1:100 Uncontrolled cardiovascular diseases, kidney diseases,lung diseases, neurological diseases, digestive diseases,metabolic disorders, immunecompromised diseases or cancer; Drug abuse or alcohol addiction Previous history of taking agents of lamivudine, adefovir, tenofovir entecavir or telbivudine Longterm use of immunosuppressor or immunomodulator 6 months before enrollment to this trial Underwent liver transplantation or liver transplantation in schedule Allergic to nucleoside or nucleotide analogues Pregnancy or in breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hepatitis B virus</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Adefovir dipivoxil</keyword>
</DOC>